Bioinformatics and network pharmacology-based investigation of matrine’s therapeutic roles in breast cancer

Read full text Summarise with VIRAT
Authors: Jinwen Qu, Zhangyu Wang, Hang Yin, Jing Quan Lan
Cited by: 0
References: 60

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Breast cancer (BC) stands out as a leading malignancy in female populations, exhibiting a gradual global increase in cases. Matrine (MAT), a bioactive alkaloid derived from traditional Chinese medicine (TCM), has demonstrated anticancer potential in multiple tumor types. This research utilized bioinformatics coupled with pharmacological network approaches to explore the therapeutic significance alongside the underlying molecular pathways of MAT in BC. Methods Differentially expressed genes (DEGs) associated with BC were retrieved from the gene expression omnibus (GEO) repository. miRNA targets were forecasted through the comparative toxicogenomics database (CTD) And SwissTargetPrediction. The overlap revealed potential therapeutic candidates, which were subsequently subjected to gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment, network analysis using cytoscape, machine learning approaches including least absolute shrinkage and selection operator (LASSO) and random forest (RF), as well as molecular docking studies. Results From the GEO database, a total of 5263 DEGs associated with BC were retrieved. Concurrently, 212 targets related to MAT were predicted utilizing CTD and SwissTargetPrediction. Cross-referencing these sets revealed 62 candidate therapeutic genes. Functional enrichment analyses including GO and KEGG suggested that these genes played key roles in apoptosis and cancer-related signaling cascades. A protein interaction network built in cytoscape highlighted 17 interconnected genes. By integrating LASSO and RF analyses, three central hub genes–cyclin D1 (CCND1), fibronectin 1 (FN1), and matrix metallopeptidase 13 (MMP13)-were identified. Molecular docking indicated strong affinity between MAT and these proteins, supporting their potential as critical targets for BC therapy.

Fields of Study & Subjects

Computational Drug Discovery Methods Bioinformatics and Genomic Networks Natural Compounds in Disease Treatment

Publication details

Journal / source
Letters in Drug Design & Discovery
Volume
23
Issue
2
Pages
100373–100373
Publication date
1 February 2026
Language
EN